Fig. 3From: Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics dataValidation of the predictive power of identified subpathway signatures in two independent datasets from CellMiner by training on datasets from TCGA, including a cisplatin and b fluorouracilBack to article page